ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014
February 10 2014 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will report its fourth quarter and year-end 2013 financial
results on Tuesday, February 25, 2014, before the market opens.
Following the announcement, at 8:30 a.m. Eastern Time, company
management will host a conference call and webcast discussion of
the results and provide a general corporate update.
The live webcast can be accessed by visiting the investor
relations section of the Company’s website at
http://investor.ariad.com. The call can be accessed by dialing
888-771-4371 (domestic) or 847-585-4405 (international) five
minutes prior to the start time and providing the pass code
36613162. A replay of the call will be available on the ARIAD
website approximately two hours after completion of the call and
will be archived for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts and Lausanne, Switzerland, is an integrated global
oncology company focused on transforming the lives of cancer
patients with breakthrough medicines. ARIAD is working on new
medicines to advance the treatment of various forms of chronic and
acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer
medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc.For InvestorsKendra Adams,
617-503-7028kendra.adams@ariad.comorFor MediaLiza Heapes,
617-621-2315liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2023 to Sep 2024